The clinical impact of the physiological effects of erythropoietin and erythropoietin-stimulating agents on the incidence of malignancy, thrombosis and hypertension: Beyond anaemia Luis M Ortega, Gabriel Contreras

The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients Vi¿nja Le¿aić, Nenad Petković, Ivko Marić, Branislava Miljković, Katarina Vučićević, Sanja Simić-Ogrizović, Vesna Pejovic, Ljubica Djukanović

Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease Maria Ángeles Guerrero Riscos, M. Ángeles Guerrero-Riscos, Rafael Montes Delgado, Rafael Montes-Delgado, Maria Seda Guzmán, María Seda-Guzmán, Juan Manuel Praena-Fernández, Juan M. Praena-Fernández